order enquiry form →

Montelukast Sodium Tablets

Brands: S.Q-Monkast; Oral Preparation; Drug Class: Bronchitis; Asthma
Specification/Dosage: 10mg
Packaging: 6 tablets x 1 blister/box, 6 tablets x 2 blister/box, 6 tablets x 3 blisters/box, Others

S.Q- Monkast(Montelukast Sodium) Uses:

Montelukast Sodium tablet is the generic form of the brand-name drug S.Q- Monkast,  Montelukast sodium tablets is an oral leukotriene receptor antagonist that specifically inhibits CysLT1 receptors in the airways, thereby improving airway inflammation and effectively controlling asthma symptoms. Montelukast sodium is a non-hormonal anti-inflammatory drug, It is suitable for the prevention and long-term treatment of asthma in adults and children over 1 year old and the treatment of allergic rhinitis. According to the “Guide to Prevention and Treatment of Bronchial Asthma” in 2008, Leukotriene modulators are the only long-term control drugs that can be used alone, in addition to inhaled hormones. They can be used as an alternative treatment for mild asthma and as a combination therapy for moderate-to-severe asthma.

  • This product is suitable for the prevention and long-term treatment of asthma in adults aged 15 and over, including preventing daytime and nighttime asthma symptoms, treating aspirin-sensitive asthma patients and preventing exercise-induced bronchoconstriction.
  • This product is suitable for alleviating the symptoms caused by allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis in adults aged 15 and over).

Side effect: This product is generally well tolerated, with mild side effects and usually does not require termination of treatment. The overall adverse reaction rate of this product is similar to that of placebo. The drug-related incidence of ≥1% in this product treatment group and higher than placebo group was abdominal pain and headache.


  • The efficacy of oral administration of this product in the treatment of acute asthma attacks has not yet been established and therefore should not be used to treat acute asthma attacks.
  • Patients should be informed to prepare appropriate rescue medications.
  • Although the dose of inhaled glucocorticoid used in combination can be gradually reduced under the guidance of a physician, but do not use this product suddenly replace inhaled or oral glucocorticoids.


  • This product can be used in combination with other conventional drugs for the prevention and long-term treatment of asthma and the treatment of allergic rhinitis.
  • In drug interaction studies, the recommended dose of this product does not have clinically significant pharmacokinetic effects on the following drugs: theophylline, prednisone, prednisolone, oral contraceptives, terfenadine, digoxin .
  • In patients with phenobarbital combined, the area under the plasma concentration-time curve of montelukast decreased by approximately 40%. However, it is not recommended to adjust the dose of this product.

Other Information

  • Active Ingredients: Montelukast Sodium 10mg
  • Standard: USP; BP; CP
  • Dossier: ACTD, CTD or According client requirement
  • Shelf life: 3 years(36 months)
  • Manufacturers(factory) made in China